Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multi-centre, parallel-arm, open, individually randomised, controlled
| Date first appeared online | |
| DOI | 10.1136/bmjopen-2024-084144 |
| Authors | Sewell B., Harris S., Fitzsimmons D. |
| Journal Name | BMJ Open |
| Volume |